Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles

DARU, Journal of Pharmaceutical Sciences

Volumn 22, Issue 1, 2014, Pages

  Jain, Darshana S ^a   Athawale, Rajani B ^a   Bajaj, Amrita N ^b   Shrikhande, Shruti S ^a   Goel, Peeyush N ^c   Nikam, Yuvraj ^c   Gude, Rajiv P ^c  

^a SNDT WOMEN S UNIVERSITY   (India)

^b SVKM S DR BHANUBEN NANAVATI COLLEGE OF PHARMACY   (India)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

C6 cell line; Gliomas; PLGA nanoparticles; Temozolomide

Indexed keywords

MITOMYCIN; NANOPARTICLE; POLYGLACTIN; SOLVENT; TEMOZOLOMIDE;

ANALYTIC METHOD; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DIALYSIS; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFECT; DRUG FORMULATION; FLOW CYTOMETRY; GLIOMA CELL; IC 50; IN VITRO STUDY; NONHUMAN; PARTICLE SIZE; SUSTAINED DRUG RELEASE; TUMOR CELL LINE; ZETA POTENTIAL;

EID: 84892766000     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-22-18     Document Type: Article

References (27)

1. State of the science in brain tumor classification. Doolittle ND, Semin Oncol Nurs 2004 20 224 230 15612598
2. Brain and other central nervous system tumors: rates, trends, and epidemiology. Gurney JG, Kadan-Lottick N, Curr Opin Oncol 2001 13 160 166 10.1097/00001622-200105000-00005 11307058
3. New strategies to deliver anticancer drugs to brain tumors. Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G, Expert Opin Drug Deliv 2009 6 1017 1032 10.1517/17425240903167942 19732031
4. Structural and functional aspects of the blood-brain barrier. Begley DJ, Brightman MW, Prog Drug Res 2003 61 39 78 14674608
5. Antitumor effects of polysorbate-80 coated gemcitabine polybutylcyanoacrylate nanoparticles in vitro and its pharmacodynamics in vivo on C6 glioma cells of a brain tumor model. Wang C-X, Huang L-S, Hou L-B, Jiang L, Yan Z-T, Wang Y-L, Chen Z-L, Brain Res 2009 1261 91 99 19401168
6. Paclitaxel nanoparticles for the potential treatment of brain tumors. Koziara JM, Lockman PR, Allen DD, Mumper RJ, J Control Release 2004 99 259 269 10.1016/j.jconrel.2004.07.006 15380635
7. Cytotoxicity of doxorubicin bound to poly (butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays. Sanchez De Juan B, Von Briesen H, Gelperina SE, Kreuter J, J Drug Target 2006 14 614 622 10.1080/10611860600866872 17090397
8. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Newlands E, Stevens M, Wedge S, Wheelhouse R, Brock C, Cancer Treat Rev 1997 23 35 61 10.1016/S0305-7372(97) 90019-0 9189180
9. Recent approaches to improve the antitumor efficacy of temozolomide. Tentori L, Graziani G, Curr Med Chem 2009 16 245 257 10.2174/092986709787002718 19149575
10. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Tian X-H, Lin X-N, Wei F, Feng W, Huang Z-C, Wang P, Ren L, Diao Y, Int J Nanomedicine 2011 6 445 452 21445277
11. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Gao K, Jiang X, Int J Pharm 2006 310 213 219 10.1016/j.ijpharm.2005.11.040 16426779
12. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. Ying X, Wen H, Lu W-L, Du J, Guo J, Tian W, Men Y, Zhang Y, Li R-J, Yang T-Y, J Control Release 2010 141 183 192 10.1016/j.jconrel.2009.09.020 19799948
13. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats. Tian W, Ying X, Du J, Guo J, Men Y, Zhang Y, Li R-J, Yao H-J, Lou J-N, Zhang L-R, Eur J Pharm Sci 2010 41 232 243 10.1016/j.ejps.2010.06.008 20600880
14. Temozolomide and treatment of malignant glioma. Friedman HS, Kerby T, Calvert H, Clin Cancer Res 2000 6 2585 2597 10914698
15. Studies on stabilization mechanism and stealth effect of Poloxamer 188 onto PLGA nanoparticles. Jain D, Athawale R, Bajaj A, Shrikhande S, Goel PN, Gude RP, Colloids Surf B Biointerfaces 2013 109 59 67 23608470
16. Fabrication of lipospheres for paclitaxel and assessment of in vitro cytotoxicity against U373 cancer cell lines. Nerkar N, Bajaj A, Shrikhande S, Jain D, Thai J Pharm Sci 2012 36 117 130
17. Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells. Dua P, Gude RP, Cancer Chemother Pharmacol 2006 58 195 202 10.1007/s00280-005-0155-8 16331498
18. Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells. Goel PN, Gude R, Mol Cell Biochem 2011 358 141 151 10.1007/s11010-011-0929-8 21725843
19. Clonogenic assay of cells in vitro. Franken NA, Rodermond HM, Stap J, Haveman J, Van Bree C, Nat Protoc 2006 1 2315 2319 10.1038/nprot.2006.339 17406473
20. Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells. Pichot C, Hartig S, Xia L, Arvanitis C, Monisvais D, Lee F, Frost J, Corey S, Br J Cancer 2009 101 38 47 10.1038/sj.bjc.6605101 19513066
21. Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. Lee HS, Seo EY, Kang NE, Kim WK, J Nutr Biochem 2008 19 313 319 10.1016/j.jnutbio.2007.05.008 17683926
22. Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 Glioma cells. Jain D, Athawale R, Bajaj A, Shrikhande S, Goel PN, Nikam Y, Gude RP, Biomed Aging Path 2013 doi:10.1016/j.biomag.2013.08.003
23. Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating. Chen H, Wang L, Yeh J, Wu X, Cao Z, Wang YA, Zhang M, Yang L, Mao H, Biomaterials 2010 31 5397 5407 10.1016/j.biomaterials.2010.03.036 20398933
24. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Frohlich E, Int J Nanomedicine 2012 7 5577 5591 23144561
25. Hallmarks of cancer: the next generation. Hanahan D, Weinberg RA, Cell 2011 144 646 674 10.1016/j.cell.2011.02.013 21376230
26. EGFR inhibition in glioma cells modulates rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth. Ramis G, Thomas-Moya E, de Mattos SF, Rodriguez J, Villalonga P, PLoS One 2012 7 38770 10.1371/journal.pone.0038770 22701710
27. Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells. Chen M, Rose AE, Doudican N, Osman I, Orlow SJ, Mol Cancer Res 2009 7 1946 1953 10.1158/1541-7786.MCR-09-0243 19934274